Greg Powell is currently the Director at GlaxoSmithKline, where responsibilities include leading a team in pharmacovigilance activities and directing GSK’s Safety Listening Lab, focusing on social media research for R&D and pharmacovigilance. Significant contributions at GSK include efforts in observational data application, development of capabilities for aggregate analysis of spontaneous data, and participation in the rollout of multiple award-winning pharmacovigilance systems. Additionally, Greg serves as an Adjunct Assistant Professor at the University of North Carolina at Chapel Hill, where the creation of a drug safety rotation for PharmD students and teaching on drug safety topics are key roles. Educational qualifications include a BS in Pharmacy from the University of North Carolina at Chapel Hill, a PharmD from the University of Florida, and an MBA from East Carolina University.
This person is not in any teams
This person is not in any offices